Hims & Hers Health Sees 24% Stock Surge Amid Novo Nordisk Partnership and Robust Earnings Reports

jueves, 1 de mayo de 2025, 2:32 pm ET1 min de lectura
HIMS--
NVO--

Hims & Hers Health's stock surged 24% after announcing a partnership with Novo Nordisk to improve obesity care access in the US. The collaboration aligns with the company's commitment to expanding its health solutions portfolio and maintaining investor interest. Despite the recent gain, the current share price remains 43.4% below analysts' consensus price target of $44.82.

Hims & Hers Health Sees 24% Stock Surge Amid Novo Nordisk Partnership and Robust Earnings Reports

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios